What is Northrop Grumman's earnings per share (EPS)?

Northrop Grumman (NOC) reported diluted earnings per share of $29.08 for fiscal year 2025. This represents a 2.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Northrop Grumman Financials

NOC

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Northrop Grumman (NOC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NOC FY2025 2026-07-21

In FY2025, flat overhead and lighter reinvestment turned modest sales growth into a stronger cash-generating year.

From FY2023 to FY2025, revenue rose only from $39.3B to $42.0B, so the recovery was not mainly a bigger-sales story. Yet free cash flow climbed from $2.1B to $3.3B as overhead stayed nearly flat and capex eased, pointing to better cash conversion and stronger fixed-cost absorption rather than simple top-line momentum.

Operating margin recovered to 10.8% in FY2025 from 6.5% in FY2023 even though revenue growth stayed moderate, which suggests the weak year was more about execution drag than a permanently thinner earnings shape. Operating cash flow of $4.8B also exceeded net income of $4.2B, giving the rebound better earnings quality than a purely accounting recovery.

Liquidity is adequate, not excessive: cash of $4.4B sits against long-term debt of $15.2B, while current assets only modestly exceed current liabilities. With goodwill still above $17.4B and shareholder payouts absorbing most free cash flow, the balance sheet looks built to keep cash circulating through the business rather than to hold a large idle cushion.

Financial Health Signals

Financial Health Score 50/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Northrop Grumman's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Northrop Grumman has an operating margin of 10.8%, meaning the company retains $11 of operating profit per $100 of revenue. This strong profitability earns a score of 72/100, reflecting efficient cost management and pricing power. This is up from 10.7% the prior year.

Growth

Northrop Grumman's revenue grew a modest 2.2% year-over-year to $42.0B. This slow but positive growth earns a score of 44/100.

Leverage

Northrop Grumman has a moderate D/E ratio of 0.91. This balance of debt and equity financing earns a leverage score of 33/100.

Liquidity

Northrop Grumman's current ratio of 1.10 is below the typical benchmark, resulting in a score of 24/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Northrop Grumman has a free cash flow margin of 7.9%, earning a moderate score of 56/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Northrop Grumman earns a strong 25.1% return on equity (ROE), meaning it generates $25 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 73/100. This is down from 27.3% the prior year.

Altman Z-Score Grey Zone

2.90

Northrop Grumman scores 2.90, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

Northrop Grumman passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.14x

For every $1 of reported earnings, Northrop Grumman generates $1.14 in operating cash flow ($4.8B OCF vs $4.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

6.8x

Northrop Grumman earns $6.8 in operating income for every $1 of interest expense ($4.5B vs $665.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$42.0B

YoY+2.2%

5Y CAGR+2.7%

10Y CAGR+6.0%

Northrop Grumman generated $42.0B in revenue in fiscal year 2025. This represents an increase of 2.2% from the prior year.

EBITDA

$6.0B

YoY+4.2%

5Y CAGR+2.3%

10Y CAGR+5.4%

Northrop Grumman's EBITDA was $6.0B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 4.2% from the prior year.

Net Income

$4.2B

YoY+0.2%

5Y CAGR+5.6%

10Y CAGR+7.7%

Northrop Grumman reported $4.2B in net income in fiscal year 2025. This represents an increase of 0.2% from the prior year.

EPS (Diluted)

$29.08

YoY+2.6%

5Y CAGR+8.9%

10Y CAGR+10.8%

Northrop Grumman earned $29.08 per diluted share (EPS) in fiscal year 2025. This represents an increase of 2.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$3.3B

YoY+26.2%

5Y CAGR+2.8%

10Y CAGR+6.9%

Northrop Grumman generated $3.3B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 26.2% from the prior year.

Cash & Debt

$4.4B

YoY+1.1%

5Y CAGR-2.1%

10Y CAGR+6.6%

Northrop Grumman held $4.4B in cash against $15.2B in long-term debt as of fiscal year 2025.

Dividends Per Share

$8.99

YoY+11.7%

5Y CAGR+9.7%

10Y CAGR+11.2%

Northrop Grumman paid $8.99 per share in dividends in fiscal year 2025. This represents an increase of 11.7% from the prior year.

Shares Outstanding

142M

YoY-2.0%

5Y CAGR-3.2%

10Y CAGR-2.4%

Northrop Grumman had 142M shares outstanding in fiscal year 2025. This represents a decrease of 2.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

10.8%

YoY+0.1pp

5Y CAGR-0.3pp

10Y CAGR-2.3pp

Northrop Grumman's operating margin was 10.8% in fiscal year 2025, reflecting core business profitability. This is up 0.1 percentage points from the prior year.

Net Margin

10.0%

YoY-0.2pp

5Y CAGR+1.3pp

10Y CAGR+1.5pp

Northrop Grumman's net profit margin was 10.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.2 percentage points from the prior year.

Return on Equity

25.1%

YoY-2.2pp

5Y CAGR-5.1pp

10Y CAGR-11.0pp

Northrop Grumman's ROE was 25.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$1.1B

YoY+0.0%

5Y CAGR+0.0%

10Y CAGR+4.4%

Northrop Grumman invested $1.1B in research and development in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Share Buybacks

$1.6B

YoY-35.4%

5Y CAGR+27.1%

10Y CAGR-6.5%

Northrop Grumman spent $1.6B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 35.4% from the prior year.

Capital Expenditures

$1.4B

YoY-17.9%

5Y CAGR+0.4%

10Y CAGR+11.9%

Northrop Grumman invested $1.4B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 17.9% from the prior year.

NOC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$42.0B+2.2%	$41.0B+4.4%	$39.3B+7.3%	$36.6B+2.6%	$35.7B-3.1%	$36.8B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$1.1B0.0%	$1.1B-8.3%	$1.2B0.0%	$1.2B+9.1%	$1.1B0.0%	$1.1B
SG&A Expenses	$4.0B+1.0%	$4.0B-0.5%	$4.0B+3.6%	$3.9B+7.7%	$3.6B+5.4%	$3.4B
Operating Income	$4.5B+3.2%	$4.4B+72.3%	$2.5B-29.5%	$3.6B-36.3%	$5.7B+39.0%	$4.1B
Interest Expense	$665.0M+7.1%	$621.0M+13.9%	$545.0M+7.7%	$506.0M-9.0%	$556.0M-6.2%	$593.0M
Income Tax	$886.0M+5.2%	$842.0M+190.3%	$290.0M-69.1%	$940.0M-51.4%	$1.9B+258.6%	$539.0M
Net Income	$4.2B+0.2%	$4.2B+103.0%	$2.1B-58.0%	$4.9B-30.1%	$7.0B+119.7%	$3.2B
EPS (Diluted)	$29.08+2.6%	$28.34+109.5%	$13.53-57.0%	$31.47-27.7%	$43.54+128.8%	$19.03

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$9.9B-15.6%	$11.7B+12.4%	$10.4B+0.7%	$10.4B+9.3%	$9.5B-11.4%	$10.7B+6.9%	$10.0B-2.2%	$10.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$971.0M-5.3%	$1.0B+4.1%	$985.0M-3.1%	$1.0B+0.9%	$1.0B+19.5%	$843.0M-14.5%	$986.0M-10.4%	$1.1B
Operating Income	$989.0M-22.2%	$1.3B+2.3%	$1.2B-12.8%	$1.4B+148.7%	$573.0M-47.4%	$1.1B-2.8%	$1.1B+2.8%	$1.1B
Interest Expense	$162.0M-7.4%	$175.0M+8.7%	$161.0M-6.9%	$173.0M+10.9%	$156.0M-2.5%	$160.0M-0.6%	$161.0M+4.5%	$154.0M
Income Tax	$155.0M-50.5%	$313.0M+40.4%	$223.0M-11.9%	$253.0M+160.8%	$97.0M-66.2%	$287.0M+77.2%	$162.0M-21.4%	$206.0M
Net Income	$875.0M-38.7%	$1.4B+29.7%	$1.1B-6.3%	$1.2B+144.1%	$481.0M-61.9%	$1.3B+23.2%	$1.0B+9.1%	$940.0M
EPS (Diluted)	$6.14	N/A	$7.67-5.9%	$8.15+145.5%	$3.32	N/A	$7.00+10.1%	$6.36

NOC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$51.4B+4.1%	$49.4B+6.0%	$46.5B+6.4%	$43.8B+2.8%	$42.6B-4.3%	$44.5B
Current Assets	$15.3B+7.1%	$14.3B+4.1%	$13.7B+9.8%	$12.5B+0.5%	$12.4B-19.0%	$15.3B
Cash & Equivalents	$4.4B+1.1%	$4.4B+40.0%	$3.1B+20.6%	$2.6B-27.0%	$3.5B-28.1%	$4.9B
Inventory	$1.3B-10.0%	$1.5B+31.2%	$1.1B+13.4%	$978.0M+20.6%	$811.0M+6.9%	$759.0M
Accounts Receivable	$1.4B+8.1%	$1.3B-12.5%	$1.5B-3.8%	$1.5B+3.0%	$1.5B-2.3%	$1.5B
Goodwill	$17.4B-0.4%	$17.5B0.0%	$17.5B0.0%	$17.5B0.0%	$17.5B0.0%	$17.5B
Total Liabilities	$34.7B+1.9%	$34.1B+7.3%	$31.7B+11.6%	$28.4B-4.1%	$29.7B-12.5%	$33.9B
Current Liabilities	$13.9B-1.7%	$14.1B+18.3%	$11.9B+3.1%	$11.6B+21.6%	$9.5B-0.5%	$9.6B
Long-Term Debt	$15.2B+3.2%	$14.7B+6.6%	$13.8B+16.8%	$11.8B-7.6%	$12.8B-10.4%	$14.3B
Total Equity	$16.7B+9.1%	$15.3B+3.3%	$14.8B-3.4%	$15.3B+18.5%	$12.9B+22.2%	$10.6B
Retained Earnings	$16.7B+8.9%	$15.3B+3.5%	$14.8B-3.5%	$15.3B+18.6%	$12.9B+23.2%	$10.5B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$50.0B-2.7%	$51.4B+4.2%	$49.3B-0.3%	$49.5B+2.0%	$48.5B-1.8%	$49.4B+2.2%	$48.3B+1.3%	$47.7B
Current Assets	$14.8B-3.4%	$15.3B+8.4%	$14.1B+0.6%	$14.0B+5.7%	$13.3B-7.1%	$14.3B-0.4%	$14.3B+0.5%	$14.3B
Cash & Equivalents	$2.1B-52.5%	$4.4B+125.0%	$2.0B+3.1%	$1.9B+12.7%	$1.7B-61.3%	$4.4B+30.9%	$3.3B+1.7%	$3.3B
Inventory	$1.4B+10.8%	$1.3B-18.9%	$1.6B+4.0%	$1.6B-1.6%	$1.6B+8.5%	$1.5B-11.6%	$1.6B+9.4%	$1.5B
Accounts Receivable	$1.8B+31.3%	$1.4B-30.7%	$2.0B-9.7%	$2.2B+21.7%	$1.8B+41.9%	$1.3B-20.9%	$1.6B-5.0%	$1.7B
Goodwill	$17.4B0.0%	$17.4B0.0%	$17.4B0.0%	$17.4B0.0%	$17.4B-0.4%	$17.5B0.0%	$17.5B0.0%	$17.5B
Total Liabilities	$32.9B-5.2%	$34.7B+4.2%	$33.3B-2.0%	$34.0B+1.5%	$33.5B-1.7%	$34.1B+1.6%	$33.5B+0.5%	$33.4B
Current Liabilities	$12.8B-7.6%	$13.9B+9.2%	$12.7B-5.5%	$13.5B-3.7%	$14.0B-1.1%	$14.1B+7.8%	$13.1B+1.5%	$12.9B
Long-Term Debt	$14.4B-5.0%	$15.2B0.0%	$15.2B0.0%	$15.2B+7.0%	$14.2B-3.6%	$14.7B0.0%	$14.7B-0.1%	$14.7B
Total Equity	$17.1B+2.6%	$16.7B+4.3%	$16.0B+3.3%	$15.5B+3.3%	$15.0B-2.0%	$15.3B+3.7%	$14.7B+3.1%	$14.3B
Retained Earnings	$17.1B+2.6%	$16.7B+4.3%	$16.0B+3.3%	$15.5B+3.1%	$15.0B-2.1%	$15.3B+3.8%	$14.7B+3.1%	$14.3B

NOC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$4.8B+8.4%	$4.4B+13.2%	$3.9B+33.6%	$2.9B-18.7%	$3.6B-17.1%	$4.3B
Capital Expenditures	$1.4B-17.9%	$1.8B-0.5%	$1.8B+23.7%	$1.4B+1.4%	$1.4B-0.4%	$1.4B
Free Cash Flow	$3.3B+26.2%	$2.6B+24.8%	$2.1B+43.2%	$1.5B-31.9%	$2.2B-25.4%	$2.9B
Investing Cash Flow	-$1.2B+34.0%	-$1.7B-10.6%	-$1.6B-27.5%	-$1.2B-160.3%	$2.1B+269.9%	-$1.2B
Financing Cash Flow	-$3.6B-154.6%	-$1.4B+20.8%	-$1.8B+32.6%	-$2.6B+62.7%	-$7.0B-1520.8%	-$432.0M
Dividends Paid	$1.3B+9.0%	$1.2B+6.3%	$1.1B+6.1%	$1.1B+7.0%	$983.0M+3.1%	$953.0M
Share Buybacks	$1.6B-35.4%	$2.5B+67.6%	$1.5B-0.3%	$1.5B-59.4%	$3.7B+656.1%	$490.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$1.7B-142.5%	$3.9B+150.3%	$1.6B+79.4%	$868.0M+155.5%	-$1.6B-160.7%	$2.6B+136.3%	$1.1B-23.4%	$1.4B
Capital Expenditures	$167.0M-74.8%	$662.0M+119.9%	$301.0M+30.3%	$231.0M-9.8%	$256.0M-68.6%	$816.0M+126.0%	$361.0M+12.8%	$320.0M
Free Cash Flow	-$1.8B-156.4%	$3.2B+157.6%	$1.3B+97.2%	$637.0M+135.0%	-$1.8B-203.3%	$1.8B+141.4%	$730.0M-33.9%	$1.1B
Investing Cash Flow	-$168.0M+74.7%	-$664.0M-121.3%	-$300.0M-591.8%	$61.0M+124.2%	-$252.0M+68.4%	-$798.0M-121.1%	-$361.0M-12.5%	-$321.0M
Financing Cash Flow	-$489.0M+37.9%	-$787.0M+34.4%	-$1.2B-67.7%	-$715.0M+16.0%	-$851.0M-13.0%	-$753.0M-11.4%	-$676.0M+24.3%	-$893.0M
Dividends Paid	$333.0M+1.2%	$329.0M-0.3%	$330.0M-0.6%	$332.0M+9.9%	$302.0M+1.0%	$299.0M-0.7%	$301.0M-0.7%	$303.0M
Share Buybacks	$68.0M-85.1%	$456.0M+64.6%	$277.0M-32.6%	$411.0M-14.4%	$480.0M+8.8%	$441.0M+37.4%	$321.0M-42.9%	$562.0M

NOC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	10.8%+0.1pp	10.7%+4.2pp	6.5%-3.4pp	9.8%-6.0pp	15.8%+4.8pp	11.1%
Net Margin	10.0%-0.2pp	10.2%+4.9pp	5.2%-8.2pp	13.4%-6.3pp	19.6%+11.0pp	8.7%
Return on Equity	25.1%-2.2pp	27.3%+13.4pp	13.9%-18.1pp	32.0%-22.2pp	54.2%+24.1pp	30.1%
Return on Assets	8.1%-0.3pp	8.5%+4.0pp	4.4%-6.8pp	11.2%-5.3pp	16.4%+9.3pp	7.2%
Current Ratio	1.10+0.1	1.01-0.1	1.15+0.1	1.08-0.2	1.30-0.3	1.60
Debt-to-Equity	0.91-0.1	0.96+0.0	0.93+0.2	0.77-0.2	0.99-0.4	1.35
FCF Margin	7.9%+1.5pp	6.4%+1.0pp	5.3%+1.3pp	4.0%-2.0pp	6.0%-1.8pp	7.8%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	10.0%-0.8pp	10.8%-1.1pp	11.9%-1.8pp	13.8%+7.7pp	6.0%-4.1pp	10.2%-1.0pp	11.2%+0.5pp	10.7%
Net Margin	8.9%-3.3pp	12.2%+1.6pp	10.5%-0.8pp	11.3%+6.3pp	5.1%-6.8pp	11.8%+1.6pp	10.3%+1.1pp	9.2%
Return on Equity	5.1%-3.4pp	8.6%+1.7pp	6.9%-0.7pp	7.6%+4.4pp	3.2%-5.1pp	8.3%+1.3pp	7.0%+0.4pp	6.6%
Return on Assets	1.8%-1.0pp	2.8%+0.5pp	2.2%-0.1pp	2.4%+1.4pp	1.0%-1.6pp	2.6%+0.4pp	2.1%+0.2pp	2.0%
Current Ratio	1.15+0.1	1.100.0	1.11+0.1	1.04+0.1	0.95-0.1	1.01-0.1	1.09-0.0	1.11
Debt-to-Equity	0.84-0.1	0.91-0.0	0.95-0.0	0.98+0.0	0.95-0.0	0.96-0.0	1.00-0.0	1.03
FCF Margin	-18.4%-46.1pp	27.6%+15.6pp	12.0%+5.9pp	6.2%+25.4pp	-19.2%-35.7pp	16.5%+9.2pp	7.3%-3.5pp	10.8%

Similar Companies

General Dynamics Corp GD

$100.9B

Howmet Aerospace Inc HWM

$112.3B

Lockheed Martin LMT

$118.6B

Transdigm Group TDG

$66.8B

Boeing BA

$164.5B

Frequently Asked Questions

What is Northrop Grumman's annual revenue?

Northrop Grumman (NOC) reported $42.0B in total revenue for fiscal year 2025. This represents a 2.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Northrop Grumman's revenue growing?

Northrop Grumman (NOC) revenue grew by 2.2% year-over-year, from $41.0B to $42.0B in fiscal year 2025.

Is Northrop Grumman profitable?

Yes, Northrop Grumman (NOC) reported a net income of $4.2B in fiscal year 2025, with a net profit margin of 10.0%.

What is Northrop Grumman's EBITDA?

Northrop Grumman (NOC) had EBITDA of $6.0B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Northrop Grumman have?

As of fiscal year 2025, Northrop Grumman (NOC) had $4.4B in cash and equivalents against $15.2B in long-term debt.

What is Northrop Grumman's operating margin?

Northrop Grumman (NOC) had an operating margin of 10.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Northrop Grumman's net profit margin?

Northrop Grumman (NOC) had a net profit margin of 10.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Northrop Grumman pay dividends?

Yes, Northrop Grumman (NOC) paid $8.99 per share in dividends during fiscal year 2025.

What is Northrop Grumman's return on equity (ROE)?

Northrop Grumman (NOC) has a return on equity of 25.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Northrop Grumman's free cash flow?

Northrop Grumman (NOC) generated $3.3B in free cash flow during fiscal year 2025. This represents a 26.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Northrop Grumman's operating cash flow?

Northrop Grumman (NOC) generated $4.8B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Northrop Grumman's total assets?

Northrop Grumman (NOC) had $51.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Northrop Grumman's capital expenditures?

Northrop Grumman (NOC) invested $1.4B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Northrop Grumman spend on research and development?

Northrop Grumman (NOC) invested $1.1B in research and development during fiscal year 2025.

Does Northrop Grumman buy back shares?

Yes, Northrop Grumman (NOC) spent $1.6B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Northrop Grumman have outstanding?

Northrop Grumman (NOC) had 142M shares outstanding as of fiscal year 2025.

What is Northrop Grumman's current ratio?

Northrop Grumman (NOC) had a current ratio of 1.10 as of fiscal year 2025, which is considered adequate.

What is Northrop Grumman's debt-to-equity ratio?

Northrop Grumman (NOC) had a debt-to-equity ratio of 0.91 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Northrop Grumman's return on assets (ROA)?

Northrop Grumman (NOC) had a return on assets of 8.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Northrop Grumman's Altman Z-Score?

Northrop Grumman (NOC) has an Altman Z-Score of 2.90, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Northrop Grumman's Piotroski F-Score?

Northrop Grumman (NOC) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Northrop Grumman's earnings high quality?

Northrop Grumman (NOC) has an earnings quality ratio of 1.14x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Northrop Grumman cover its interest payments?

Northrop Grumman (NOC) has an interest coverage ratio of 6.8x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Northrop Grumman?

Northrop Grumman (NOC) scores 50 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.